ARGOS THERAPEUTICS INC's ticker is ARGSXXXX and the CUSIP is 040221103. A total of 1 filers reported holding ARGOS THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $4,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pharmstandard International S.A. | 13,242,279 | $64,887,000 | 55.88% |
| Pharmstandard International S.A. | 5,120,604 | $27,390,000 | 23.59% |
| SANDERS MORRIS HARRIS LLC | 292,512 | $1,433,000 | 0.66% |
| WALL STREET ASSOCIATES | 82,850 | $406,000 | 0.27% |
| WASATCH ADVISORS LP | 3,254,211 | $15,946,000 | 0.24% |
| ALTRINSIC GLOBAL ADVISORS LLC | 172,505 | $845,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 121,524 | $595,000 | 0.01% |
| Alyeska Investment Group, L.P. | 200,000 | $980,000 | 0.01% |
| Acrospire Investment Management LLC | 1,800 | $9,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1,024,428 | $5,020,000 | 0.00% |